Athenex Inc.

Athenex Inc.

NASDAQ:ATNX
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of cancer. Its Orascover more
Buy & Sell
Shareholders
Kwan Rudolf Bluewhale
15 Nov 2018
Increased 5K direct shares of Athenex Inc.
Gain: ▲ +15.7%
Type: Open Market/Private Sale
Executed On: 14 Nov 2018
Teachers Advisors, LLC Billionaire
14 Nov 2018
Increased 3.58K shares of Athenex Inc.
Gain: ▼ -34%
Executed On: 30 Sept 2018
Goldman Sachs Group Inc Billionaire
14 Nov 2018
Reduced 6.32K shares of Athenex Inc.
Executed On: 30 Sept 2018
Man Group PLC Billionaire
14 Nov 2018
Increased 12.95K shares of Athenex Inc.
Gain: ▼ -34%
Executed On: 30 Sept 2018
Metlife Investment Advisors, LLC Billionaire
14 Nov 2018
Increased 11.13K shares of Athenex Inc.
Gain: ▼ -34%
Executed On: 30 Sept 2018